Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
218.91B | 277.24B | 207.61B | 233.93B | 211.91B | Gross Profit |
22.75B | 25.76B | 21.72B | 22.36B | 21.34B | EBIT |
12.93B | 15.75B | 11.72B | 12.38B | 11.22B | EBITDA |
16.08B | 19.14B | 14.91B | 15.52B | 14.43B | Net Income Common Stockholders |
11.63B | 12.64B | 11.90B | 10.34B | 9.43B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
86.91B | 70.75B | 63.49B | 70.77B | 63.81B | Total Assets |
175.01B | 179.99B | 171.53B | 161.89B | 150.16B | Total Debt |
11.06B | 12.22B | 12.09B | 12.01B | 12.08B | Net Debt |
-61.23B | -45.20B | -37.70B | -40.36B | -37.13B | Total Liabilities |
40.14B | 53.24B | 51.99B | 52.64B | 49.39B | Stockholders Equity |
134.87B | 126.75B | 119.53B | 109.25B | 100.77B |
Cash Flow | Free Cash Flow | |||
24.01B | 17.81B | -5.19B | 9.79B | -4.02B | Operating Cash Flow |
26.93B | 20.77B | -1.23B | 12.59B | 2.12B | Investing Cash Flow |
-8.35B | -9.85B | -3.06B | -2.36B | -4.78B | Financing Cash Flow |
-7.94B | -7.44B | -3.75B | -3.86B | -2.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $21.60T | 18.93 | 14.40% | 0.54% | 9.56% | 26.52% | |
73 Outperform | ¥3.49T | 23.65 | 2.54% | 0.23% | 12.16% | ||
70 Outperform | $3.70T | 11.09 | 7.23% | 2.45% | 1.72% | -33.60% | |
69 Neutral | $5.67T | 25.47 | 11.70% | 0.86% | -5.48% | -11.96% | |
68 Neutral | $95.51B | 9.99 | 6.83% | 1.97% | -11.06% | -22.41% | |
63 Neutral | $4.27B | 11.36 | 5.38% | 214.64% | 4.14% | -9.01% | |
44 Neutral | ¥545.18B | ― | ― | -5.57% | 38.15% |